Align Technology, Inc. (ALGN) Earnings Call Transcripts

Align Technology, Inc.'s Latest Earnings Call - Q2 FY2026

In the second quarter of fiscal 2026, Align Technology reported revenues of $1.06 billion, a 4.3% increase year-over-year, driven by record Clear Aligner volumes of 692,000 cases and 8.2% Clear Aligner revenue growth. The company exceeded expectations with a non-GAAP operating margin of 22.9%, while net income per diluted share was $2.64, up 6% year-over-year. Management maintained its fiscal 2026 revenue growth guidance of 3% to 4% but adjusted expectations for Systems and Services revenue to decline by 6% to 8% year-over-year due to a continued shift towards lower-priced scanners and flexible acquisition models.

Reported metrics

Guidance from management

Align expects Q3 '26 revenues between $1 billion and $1.020 billion, with Clear Aligner volume growth projected at mid-single digits. The company maintained its full-year revenue growth guidance of 3% to 4%, while lowering Systems and Services revenue growth expectations to a decline of 6% to 8%.

What management said

And I would add that patient financing, expanding that patient financing, we are seeing some traction there. We want to continue that. But that helps that potential patient decide if they want to go into treatment.

Brandon, it's Joe. I would just start off by saying stable from a North America standpoint. There is a lot of fluctuation when you look at different regions, if you look at the Northeast versus Florida, California, whatever. And I don't want to go into specificity of that. But overall, I would call it stable. The DSOs continue to grow, as I mentioned in my script, overall. But I would say, basically, what we've seen...

What analysts pressed on

Analysts expressed concerns about the stability of the North American retail channel and the impact of macroeconomic pressures on consumer spending. There were also questions regarding the effectiveness of new financing options in driving patient conversions and the potential long-term effects of the U.K. VAT ruling on profitability.

Main topics on the call

• Clear Aligner Volume Growth — Clear Aligner shipments reached a record 692,000 cases, reflecting a 7.4% year-over-year increase. Management noted, "Growth was broad-based across customer channels, patient segments and geographies," indicating strong ...
• Systems and Services Revenue Decline — Systems and Services revenues fell to $185.3 million, down 10.8% year-over-year, primarily due to lower scanner ASPs and a shift towards leasing models. Management stated, "These options lower the initial cost for custom...
• Strategic Initiatives with Elliott Management — Align announced plans to add three new independent directors and initiated a comprehensive strategic review to enhance commercial execution. Management emphasized, "These initiatives... build on work underway across the ...
• Gross Margin Improvement — Overall gross margin improved to 71.7%, up 1.8 points year-over-year, driven by operational efficiencies and higher Clear Aligner ASPs. Management noted, "Margin expansion is increasingly driven by lower refinement rates...

Read the full Align Technology, Inc. transcript (Q2 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 81 Align Technology, Inc. earnings call transcripts on record, spanning January 29, 2020 to July 29, 2026. Based on this history, Align Technology, Inc. reports quarterly. The most recent call on file is dated July 29, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

ALGN

Exchange

NasdaqGS

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

81

First call

January 29, 2020

Most recent

July 29, 2026

Reporting cadence

quarterly